SynCore Biotechnology (Taiwan) Buy Hold or Sell Recommendation
| 4192 Stock | TWD 35.60 0.05 0.14% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding SynCore Biotechnology Co is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell SynCore Biotechnology Co given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for SynCore Biotechnology Co, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out SynCore Biotechnology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as SynCore and provide practical buy, sell, or hold advice based on investors' constraints. SynCore Biotechnology Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
SynCore |
Execute SynCore Biotechnology Buy or Sell Advice
The SynCore recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on SynCore Biotechnology Co. Macroaxis does not own or have any residual interests in SynCore Biotechnology Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute SynCore Biotechnology's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves slightly opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
SynCore Biotechnology Trading Alerts and Improvement Suggestions
| SynCore Biotechnology had very high historical volatility over the last 90 days | |
| The company reported the revenue of 6.94 M. Net Loss for the year was (458.6 M) with profit before overhead, payroll, taxes, and interest of 2.97 M. | |
| SynCore Biotechnology Co has accumulated about 380.81 M in cash with (229.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.57. | |
| Roughly 67.0% of the company shares are owned by insiders or employees |
SynCore Biotechnology Returns Distribution Density
The distribution of SynCore Biotechnology's historical returns is an attempt to chart the uncertainty of SynCore Biotechnology's future price movements. The chart of the probability distribution of SynCore Biotechnology daily returns describes the distribution of returns around its average expected value. We use SynCore Biotechnology Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of SynCore Biotechnology returns is essential to provide solid investment advice for SynCore Biotechnology.
| Mean Return | 0.05 | Value At Risk | -2.79 | Potential Upside | 3.99 | Standard Deviation | 3.32 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of SynCore Biotechnology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
SynCore Biotechnology Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to SynCore Biotechnology or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that SynCore Biotechnology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a SynCore stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | -0.5 | |
σ | Overall volatility | 3.51 | |
Ir | Information ratio | 0.02 |
SynCore Biotechnology Volatility Alert
SynCore Biotechnology Co shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure SynCore Biotechnology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact SynCore Biotechnology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.SynCore Biotechnology Fundamentals Vs Peers
Comparing SynCore Biotechnology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze SynCore Biotechnology's direct or indirect competition across all of the common fundamentals between SynCore Biotechnology and the related equities. This way, we can detect undervalued stocks with similar characteristics as SynCore Biotechnology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of SynCore Biotechnology's fundamental indicators could also be used in its relative valuation, which is a method of valuing SynCore Biotechnology by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare SynCore Biotechnology to competition |
| Fundamentals | SynCore Biotechnology | Peer Average |
| Return On Equity | -0.43 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Operating Margin | (13.97) % | (5.51) % |
| Current Valuation | 2.86 B | 16.62 B |
| Shares Outstanding | 115.08 M | 571.82 M |
| Shares Owned By Insiders | 66.92 % | 10.09 % |
| Price To Book | 9.34 X | 9.51 X |
| Price To Sales | 221.58 X | 11.42 X |
| Revenue | 6.94 M | 9.43 B |
| Gross Profit | 2.97 M | 27.38 B |
| EBITDA | (404.13 M) | 3.9 B |
| Net Income | (458.6 M) | 570.98 M |
| Cash And Equivalents | 380.81 M | 2.7 B |
| Cash Per Share | 4.57 X | 5.01 X |
| Total Debt | 61.11 M | 5.32 B |
| Debt To Equity | 9.40 % | 48.70 % |
| Current Ratio | 5.04 X | 2.16 X |
| Book Value Per Share | 2.87 X | 1.93 K |
| Cash Flow From Operations | (229.86 M) | 971.22 M |
| Earnings Per Share | (3.73) X | 3.12 X |
| Number Of Employees | 65 | 18.84 K |
| Beta | 1.14 | -0.15 |
| Market Capitalization | 2.88 B | 19.03 B |
| Total Asset | 824.44 M | 29.47 B |
| Z Score | 28.2 | 8.72 |
| Net Asset | 824.44 M |
SynCore Biotechnology Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as SynCore . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 35.6 | |||
| Day Typical Price | 35.6 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.05 | |||
| Relative Strength Index | 50.81 |
About SynCore Biotechnology Buy or Sell Advice
When is the right time to buy or sell SynCore Biotechnology Co? Buying financial instruments such as SynCore Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having SynCore Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run RUB Crypto Assets Thematic Idea Now
RUB Crypto Assets
An experimental p2p digital currency that is accepted by many vendors in Russian Ruble. The RUB Crypto Assets theme has 0 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize RUB Crypto Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for SynCore Stock Analysis
When running SynCore Biotechnology's price analysis, check to measure SynCore Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SynCore Biotechnology is operating at the current time. Most of SynCore Biotechnology's value examination focuses on studying past and present price action to predict the probability of SynCore Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SynCore Biotechnology's price. Additionally, you may evaluate how the addition of SynCore Biotechnology to your portfolios can decrease your overall portfolio volatility.